Valinomycin cas no:2001-95-8
Synonyms: 1,7,13,19,25,31-Hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane-2,5,8,11,14,17,20,23,26,29,32,35-dodecone,3,6,9,15,18,21,27,30,33-nonaisopropyl-12,24,36-trimethyl- (7CI);Cyclo(D-a-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-a-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-a-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl);NSC 122023;Valinomicin;
NameValinomycin
CAS2001-95-8
Synonyms1,7,13,19,25,31-Hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane-2,5,8,11,14,17,20,23,26,29,32,35-dodecone,3,6,9,15,18,21,27,30,33-nonaisopropyl-12,24,36-trimethyl- (7CI);Cyclo(D-a-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-a-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-a-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl);NSC 122023;Valinomicin;
EINECS(EC#)217-896-6
Molecular FormulaC54H90 N6 O18
Molecular Weight1111.3218
AppearanceWhite solid.
refractive index1.448
storage temp2-8°C
Globally Harmonized System of Classification adn Labelling of Chemicals(GHS)
Hazardclass6.1(a)
Hazard Xn: Harmful;
Risk R27/28
Safety
Poison by ingestion, skin contact, intraperitoneal, and subcutaneous routes. When heated to decomposition it emits toxic fumes of NOx.
When heated to decomposition, VALINOMYCIN emits toxic fumes of nitrogen oxides.
Safety Information of Valinomycin (2001-95-8):
Hazard Codes: Xn
,T.gif)
Risk Statements: 27/28-36/37/38
27: Very Toxic in contact with skin
28: Very Toxic if swallowed
36: Irritating to the eyes
37: Irritating to the respiratory system
38: Irritating to the skin
Safety Statements: 36-45-36/37-28-37/39-26
26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice
28: After contact with skin, wash immediately with plenty of ... (to be specified by the manufacturer)
36: Wear suitable protective clothing
37: Wear suitable gloves
39: Wear eye/face protection
45: In case of accident or if you feel unwell, seek medical advice immediately (show label where possible)
Valinomycin (2001-95-8) is highly toxic orally.
Organism |
Test Type |
Route |
Reported Dose (Normalized Dose) |
Effect |
Source |
mouse |
LD50 |
intraperitoneal |
390ug/kg (0.39mg/kg) |
|
National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. Vol. JAN1986, |
mouse |
LD50 |
intravenous |
180ug/kg (0.18mg/kg) |
|
Cancer Research. Vol. 46, Pg. 5518, 1986. |
mouse |
LD50 |
oral |
2500ug/kg (2.5mg/kg) |
|
"Antibiotics: Origin, Nature, and Properties," Korzyoski, T., et al., eds., Washington, DC, American Soc. for Microbiology, 1978Vol. 1, Pg. 325, 1978. |
mouse |
LD50 |
subcutaneous |
4140ug/kg (4.14mg/kg) |
|
Antibiotics and Chemotherapy Vol. 12, Pg. 482, 1962. |
rabbit |
LD50 |
skin |
5mg/kg (5mg/kg) |
BEHAVIORAL: TREMOR
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD |
Drug and Chemical Toxicology. Vol. 8, Pg. 451, 1985. |
rat |
LD50 |
intraperitoneal |
800ug/kg (0.8mg/kg) |
BEHAVIORAL: TREMOR
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD |
Drug and Chemical Toxicology. Vol. 8, Pg. 451, 1985. |
rat |
LD50 |
oral |
4mg/kg (4mg/kg) |
BEHAVIORAL: TREMOR
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD |
Drug and Chemical Toxicology. Vol. 8, Pg. 451, 1985. |